- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04944472
Possibilities of Perceiving Information on the Primary Prevention of Cardiovascular Diseases in Persons Suffering From Essential Hypertension Through a Social Network (SocialCor)
Opportunities for the Perception of Information on the Primary Prevention of Cardiovascular Diseases in Persons Suffering From Hypertension Through the Social Network Instagram
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
To study the potential of the Instagram social network in increasing the medical literacy of people with essential hypertension and to develop methodological approaches to informing the population about the primary prevention of cardiovascular diseases through social networks, including hypertension.
- To assess the level of knowledge about risk factors and cardiovascular diseases among users of social networks with essential hypertension.
- Conduct a comparative assessment of the impact of the type of information materials for patients in social networks (Group I - text, Group II - video, Group III - video + text, Group IV - text + video) on the level of its understanding and assimilation by persons with essential hypertension.
- To study the possibilities of perceiving information on the primary prevention of cardiovascular diseases, depending on the gender, age and social status of users of social networks suffering from hypertension.
The research site is the social network Instagram, 4 new accounts will be created to complete the assigned tasks.
An adapted HDKQ (Heart Disease Knowledge Questionnaire) with additional gender, age and social status questions will be sent to those eligible for inclusion before the start of the educational program. Respondents to the questions of the questionnaire should be sent in text format to the private messages of the project account.
The format of interaction with the audience includes 8 text publications up to 4 thousand characters and 8 video publications up to 5 minutes long.
Text and video publications will be identical in terms of text content, and they will also reflect the answers to each question of the HDKQ questionnaire.
Publication topics:
- Risk factors for cardiovascular disease.
- Healthy food for the heart.
- "Good" and "bad" cholesterol. What is important to know?
- Physical activity. How much movement does it take to keep your heart healthy?
- Overweight and obesity.
- Smoking as a risk factor for cardiovascular diseases.
- Hypertension: diagnosis, treatment goals.
- Myocardial infarction is one of the most formidable cardiovascular complications.
All participants will be divided into 4 groups (4 separate accounts), similar in gender, age and social status:
in group I, project participants will only be presented with video publications on each of the declared topics (8 in total), in group II - only text publications (total 8), in group III - first text publications, and then video publications (16 in total), in group IV - first video publications, and then text publications (16 in total).
Upon completion of the educational program, participants will again be asked to answer the questions of the adapted HDKQ (Heart Disease Knowledge Questionnaire) questionnaire.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Moscow, Russian Federation
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Having a diagnosis of arterial hypertension
- Informed consent signed by the respondent.
Exclusion Criteria:
1. No diagnosis of arterial hypertension
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
group I
All participants will be divided into 4 groups (4 separate accounts), similar in gender, age and social status: in group I, project participants will only be presented with video publications on each of the declared topics (8 in total). |
Studying the possibilities of perceiving information on the primary prevention of cardiovascular diseases in persons suffering from hypertension through the social network Instagram
|
|
group II
All participants will be divided into 4 groups (4 separate accounts), similar in gender, age and social status: in group II - only text publications (total 8). |
Studying the possibilities of perceiving information on the primary prevention of cardiovascular diseases in persons suffering from hypertension through the social network Instagram
|
|
group III
All participants will be divided into 4 groups (4 separate accounts), similar in gender, age and social status: in group III - first text publications, and then video publications (16 in total). |
Studying the possibilities of perceiving information on the primary prevention of cardiovascular diseases in persons suffering from hypertension through the social network Instagram
|
|
group IV
All participants will be divided into 4 groups (4 separate accounts), similar in gender, age and social status: in group IV - first video publications, and then text publications (16 in total). |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Awareness of risk factors for arterial hypertension as measured by the HDKQ questionnaire
Time Frame: Before and after school
|
Before and after school
|
Collaborators and Investigators
Investigators
- Study Director: S. P. Morozov, Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department
- Study Director: A. V. Vladzymyrskyy, Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021/1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prevention, Arterial Hypertension
-
Taipei Veterans General Hospital, TaiwanMinistry of Health and Welfare, TaiwanNot yet recruitingHypertension Prevention and Management
-
VIVUS LLCNot yet recruitingPulmonary Arterial Hypertension | Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) | Pulmonary Arterial Hypertension (PAH) | Pulmonary Arterial Hypertension WHO Group I | Pulmonary Arterial Hypertension PAH
-
Rutgers, The State University of New JerseyRecruitingPulmonary Arterial Hypertension | Pulmonary Hypertension | Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) | Pulmonary Arterial Hypertension of Congenital Heart Disease | Pulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder) | Pulmonary Arterial and Chronic Thromboembolic... and other conditionsUnited States
-
Inhibikase TherapeuticsNot yet recruitingPulmonary Arterial Hypertension (PAH)
-
Philipps University MarburgMSD Sharp & Dohme GmbH, GermanyNot yet recruiting
-
Stanford UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of MichiganNot yet recruitingPulmonary Arterial Hypertension (PAH)United States
-
University of Sao Paulo General HospitalRecruitingPulmonary Arterial Hypertension (PAH)Brazil
-
University Hospital, BrestNot yet recruitingPulmonary Arterial Hypertension (PAH)France
-
Shanghai Zhongshan HospitalNot yet recruitingPulmonary Arterial Hypertension (PAH)
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
Clinical Trials on HDKQ questionnaire
-
H. Lee Moffitt Cancer Center and Research InstituteSan Diego State University; University of Minnesota; University of ArizonaCompletedAnxiety | Psychological StressUnited States
-
Centre Hospitalier Universitaire de NiceCompletedGeneral Population | TDAH | Children Aged 5 to 18 YearsFrance
-
Stanford UniversityRecruitingAstigmatism | Nearsightedness | FarsightednessUnited States
-
University Medical Center GoettingenCompletedOrofacial Pain | Sleep ProblemsGermany
-
University of LiegeCompletedCritical Illness | Covid19 | Psychological Stress | FamilyBelgium
-
Imperial College Healthcare NHS TrustNot yet recruitingCervical Myelopathy
-
Children's Hospitals and Clinics of MinnesotaCompletedFirearm Injury | Firearm Safety | Firearm OwnershipUnited States
-
Imperial College LondonRoyal Marsden NHS Foundation Trust; University College London Hospitals; The... and other collaboratorsCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
Rabin Medical CenterCompleted